The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib (Q35925610)
Jump to navigation
Jump to search
scholarly article
Language | Label | Description | Also known as |
---|---|---|---|
English | The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib |
scholarly article |
Statements
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib (English)
Keiryn L Bennett
Uwe Rix
Tilmann Bürckstümmer
Uwe Schmidt
Michael Kneidinger
Gregor Schütze
1 reference
1 reference